A Registered Cohort Study on α-Synucleinopathy
A Registered Observational Cohort Study on α-Synucleinopathy
Fujian Medical University Union Hospital
500 participants
Sep 1, 2021
OBSERVATIONAL
Conditions
Summary
α-Synucleinopathy is a cluster of neurodegenerative disease with motor and non-motor symptom. The data to be collected is intended to help healthcare providers make important medical decisions concerning α-synucleinopathy, through an enhanced understanding of the natural history, progression and multi-omics datasets of α-synucleinopathy.
Eligibility
Inclusion Criteria2
- Participants with a clinical diagnosis of primary α-synucleinopathy
- Unrelated healthy controls
Exclusion Criteria3
- Patients with secondary α-synucleinopathy that cannot be excluded.
- Patients with other neurological disorders.
- Pregnant or lactating women.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Neuropsychological assessment, brain MRI, electroencephalogram and biomarker datas will be collected
Neuropsychological assessment, brain MRI, electroencephalogram and biomarker datas will be collected
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05527067